Market capitalization | $413.95m |
Enterprise Value | $378.37m |
P/E (TTM) P/E ratio | 26.84 |
EV/FCF (TTM) EV/FCF | 9.50 |
EV/Sales (TTM) EV/Sales | 1.33 |
P/S ratio (TTM) P/S ratio | 1.45 |
P/B ratio (TTM) P/B ratio | 1.99 |
Revenue growth (TTM) Revenue growth | 5.31% |
Revenue (TTM) Revenue | $285.05m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
5 Analysts have issued a Tactile Systems Technology forecast:
5 Analysts have issued a Tactile Systems Technology forecast:
Sep '24 |
+/-
%
|
||
Revenue | 285 285 |
5%
5%
|
|
Gross Profit | 206 206 |
10%
10%
|
|
EBITDA | 28 28 |
45%
45%
|
EBIT (Operating Income) EBIT | 21 21 |
84%
84%
|
Net Profit | 15 15 |
38%
38%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Tactile Systems Technology, Inc. is a medical technology company. It develops and provides innovative medical devices for the treatment of chronic diseases at home. The company focus on advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. It possesses a platform to deliver at-home healthcare solutions throughout the United States. Tactile Systems Technology was founded on January 30, 1995 and is headquartered in Minneapolis, MN.
Head office | United States |
CEO | Sheri Dodd |
Employees | 992 |
Founded | 1995 |
Website | www.tactilemedical.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.